Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
Clinical trial NCT01817582 · COMPLETED
Trial details
- NCT number
- NCT01817582
- Sponsor
- Bausch & Lomb Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-17
- Primary completion
- 2014-01-10
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.